Director Hank Cohn sold 1,600,000 shares of IVFH at $1.20, reducing stake 51.2% from 3,125,000 to 1,525,000 shares.
Cohn executed a substantial disposal of 1,600,000 shares (1.60M shares) valued at $1,920,000.00 ($1.9M), cutting his holdings by more than half from 3,125,000 shares (3.12M shares) to 1,525,000 shares (1.52M shares). This occurs in a stock trading near its 52-week high of $1.40—the transaction at $1.20 represents a 4.3% discount to that peak, but the stock has appreciated 9.8% over the prior 30 days and 39.6% over 90 days. The company's fundamentals present a mixed picture: while the latest quarter showed revenue of $15,730,113.00 ($15.7M) and net income of $1,425,874.00 ($1.4M), annual revenue declined 9.8% year-over-year and the company was unprofitable over its most recent full fiscal year. A director reducing his position by over half deserves scrutiny, particularly given the recent price momentum and the company's deteriorating revenue trajectory.